Purpose: Detecting sight-threatening retinopathy of prematurity (ROP) relies on a diagnostic examination (DE) performed by an experienced ophthalmologist. An alternative may be a telemedicine system where retinal images of at-risk infants are graded by readers to determine features of ROP indicating the need for a DE. Methods: The multicenter Telemedicine Approaches to Evaluating Acute-phase ROP (e-ROP) Study is a cohort study of 2000 infants with birth weights 51251 g. At each visit, ophthalmologists perform DEs and non-physician imagers obtain iris and five retinal images with the disc positioned in the center, right, left, up and down. Images are uploaded to a secure server for grading by non-physician readers for the detection of plus disease, stage 3 ROP and/or zone I disease, any of which indicates ''referral-warranted ROP'' (RW-ROP). Images from all infants with RW-ROP and a random sample of infants without RW-ROP (based on DEs) are selected for grading. Gradings are compared to DEs to determine the validity and evaluate reliability, feasibility, safety, and cost-effectiveness of the telemedicine system. Results: e-ROP is conducted in 12 Clinical Centers in the US and Canada with Study Headquarters, the Data Coordinating Center and the Image Reading Center in Philadelphia and the ROP Data Center in Oklahoma City. A total of 27 study center coordinators, 34 ophthalmologists, 26 imagers, and 4 readers have been certified. All study data are submitted using a secure web-based system. Conclusion: The design and findings of this study will be useful to conduct other ROP studies or evaluate telemedicine for other diseases.
INTRODUCTION
ROP is a leading cause of avoidable childhood blindness and is becoming an increasing problem in underserved areas of the US and Canada as well as in countries with rapidly developing neonatal intensive care systems. 1, 2 At present, premature infants requiring treatment are identified by ophthalmologists with ROP expertise, who visit neonatal intensive care units (NICUs) to examine at-risk infants and often must return for multiple examinations. This is an inefficient use of skilled and costly personnel because fewer than 10% of infants examined require treatment. [3] [4] [5] There are two additional challenges in providing the required examinations for infants at risk for ROP. First, there are too few experts in ROP worldwide to meet the growing demand for ROP evaluations. The limited number of providers with the specialized training required has dwindled in the US and Canada as some ophthalmologists have stopped examining infants because of workflow inconvenience, low reimbursement and/or the substantial legal liability associated with misdiagnosis or missed examinations. 6, 7 Second, there is an inherent variability in examination results 8 which may lead to missed opportunities to treat at an appropriate time. A potential solution to address both decreasing availability of clinicians who can evaluate ROP and variability in the quality of evaluations is to develop a telemedicine system that uses retinal imaging to detect sight-threatening disease in an efficient and cost-effective manner. Ells and colleagues 9 introduced the term ''referral-warranted ROP'' (RW-ROP) in 2003 to describe eyes with ROP that had high-risk characteristics such as stage 3 ROP, plus disease or any very posterior ROP (i.e. in zone I; see Figure 1 for an example of RW-ROP). Eyes with RW-ROP require careful evaluation by an ophthalmologist with a substantial proportion requiring treatment.
Several approaches to capture still images in wide or narrow fields-of-view, as well as video sequences with indirect ophthalmoscopy, have been used to document retinal findings in ROP. [10] [11] [12] Currently, the most commonly used digital camera for ROP is a wide-field digital camera, the RetCam (Clarity Medical Systems Inc, Pleasanton, CA, USA) that provides a 130 field of view. Harrison first described imaging the retina of premature infants using the RetCam system in 1998. 13 To date, there have been a series of studies using various approaches and examining different components of an overall system for ROP telemedicine. [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] These studies had widely different, sometimes contradictory, results and variations in reported sensitivity and specificity based on the criteria used to interpret the retinal image. In most previous studies both imaging and image reading had been done by ophthalmologists.
A recent report by Chiang and co-authors emphasized the strengths and weaknesses of reported studies that used a wide-angle camera to capture images of infants at risk for ROP. 29 We report the design of Telemedicine Approaches to Evaluating Acute-phase ROP (e-ROP), a large, multicenter, adequately powered study, supported by the National Eye Institute of the National Institutes of Health. As shown in Table 1 , this study is undertaken to evaluate the validity, reliability, feasibility, safety and relative cost-effectiveness of a digital imaging system used by non-ophthalmologists to identify infants with RW-ROP.
MATERIALS AND METHODS

Study Organization and Personnel
The study is directed by the office of the study chair under the guidance of the study principal investigator (PI) and the project director at the Children's Hospital of Philadelphia. The PI also serves as chair of the executive, operations and editorial committees and acts as clinical adjudicator for selected images. The data coordinating center (DCC) and the image reading center are located at the University of Pennsylvania. The DCC consists of a director, systems analyst and biostatistician and the image reading center consists of a director who manages the operations of the four trained readers, a lead expert reader, and two expert readers. The director also acts as a supervising reader in the image grading adjudication process. The Inoveon ROP Data Center (IRDC) is managed by the PI at the University of Oklahoma Health Sciences Center and technical development and project support are directed by the Inoveon management team. The cost-effectiveness evaluation is directed by a PI at Duke University. Other e-ROP committees are listed in Figure 2 . In addition, the National Eye Institute convenes a Data Monitoring and Oversight Committee that provides valuable guidance and advice throughout the study. A complete listing of the e-ROP study group is provided in the Appendix at the end of this paper. The study is registered with the clinicaltrials.gov national registry (NCT01264276). The institutional review boards of all participating entities and institutions granted approval for participation in the study.
Study Population
Infants eligible for enrollment in the e-ROP study are those with birth weights 51251 g who qualify for the diagnostic examinations that are performed as part of participating clinical center protocols. Other criteria for e-ROP eligibility include likely survival to 28 days and likely to remain in the NICU for serial ROP examinations. Parents/guardians of eligible infants are approached for consent and infants are enrolled in the study if parents/guardians consent.
Exclusion criteria for potential e-ROP subjects are: (1) postmenstrual age (PMA) 439 weeks at first opportunity for imaging unless transferred in for treatment; (2) admission to a clinical center NICU with ROP already regressing or treated; (3) presence of a significant media opacity precluding visualization of the retina, or; (4) major ocular or systemic congenital abnormality.
Study Procedures
Clinical Center Personnel and Activities Figure 2 shows the 12 participating clinical centers in the US and Canada. These centers were selected based on their participation in previous multicenter clinical trials of ROP treatments (Cryotherapy for ROP, 30 Early Treatment for ROP 31 ) and due to large number of infants at risk for ROP in their NICUs. Each clinical center research team consists of study-certified personnel including the PI, ophthalmologists who perform the diagnostic examinations, at least one study coordinator responsible for enrolling infants and insuring data submission, and at least one certified ROP imager (CRI) who undertakes digital retinal imaging of study infants. e-ROP investigators at clinical centers attended a technical group meeting and completed general and role-specific knowledge assessments prior to study enrollment. All e-ROP study data are recorded either directly at the bedside using a tablet computer or recorded on paper and entered into the web-based data server from the clinical center.
Ophthalmological Examinations
All study diagnostic examinations are conducted by board certified ophthalmologists experienced in either vitreo-retinal diseases or pediatric ophthalmology, who have completed the e-ROP Study certification process. As part of the certification process, the study chair visited each participating clinical center and performed at least 4-paired examinations with the clinical center PI. The clinical center PI then performed at least 4-paired examinations with each of the other clinical center ophthalmologists. In addition, the examining ophthalmologists underwent knowledge assessment examinations. Objective: Evaluate the validity, reliability, feasibility, safety, and relative cost-effectiveness of a telemedicine system to detect eyes of at-risk babies in need of a diagnostic evaluation by an ophthalmologist experienced in ROP. Study population: Premature babies (N = 2000) with birth weights 51251 g who meet current ROP screening guidelines in 12 NICUs in the USA and Canada. Procedures: Babies undergo sequential ROP imaging in both eyes using RetCam, in addition to a standard diagnostic examination performed by a study-certified ophthalmologist experienced in ROP. Digital images, obtained by a non-physician certified ROP imager (CRI), are downloaded to the server for remote evaluation by trained readers and expert readers. Results of readers' evaluations are compared to the presence or absence of RW-ROP based on the diagnostic examination conducted at the same session and without knowledge of the digital image findings by the clinical center ophthalmologist.
Outcome measures:
Validity (sensitivity, specificity): Assessed by comparing the evaluations of digital images by trained readers to findings of an examination performed by a study-certified ophthalmologist, rigorously trained in ROP diagnostic examinations; Reliability: Assessed by inter-and intra-reader agreement for deciding whether digital images indicate that an eye has RW-ROP; Feasibility: Determine whether imaging evaluation can be achieved for each baby; Safety: Assessed by examining ocular and systemic complications from digital imaging compared with those from examinations performed by a study-certified ophthalmologist using indirect ophthalmoscopy; Relative cost-effectiveness: Assessed by comparing the cost and benefit of a telemedicine system to standard care, adjusted for the varying distribution of patient populations across each NICU and the local availability of eye care.
ROP, retinopathy of prematurity; NICU, neonatal intensive care unit; RW-ROP, referral-warranted ROP.
Enrolled infants undergo a series of ROP diagnostic examinations of both eyes. In general, the initial diagnostic eye examination for ROP occurs in the NICU at four weeks after birth or at 32 weeks PMA. For infants with gestational age 528 weeks, the protocol at the clinical center determines the timing of the initial diagnostic examination.
Follow-up diagnostic examinations are performed at least as often as every other week unless medically contraindicated. The follow-up schedule or a decision to treat is determined by the examining ophthalmologist based solely on the findings of the examination. The results of the ROP examination are summarized using the 2005 international classification. 32 This classification, any other findings or the presence of any potential ocular or systemic adverse events such as corneal abrasion, apnea or bradycardia are recorded on the e-ROP diagnostic exam form and uploaded to the e-ROP central server. The results of the diagnostic examination are recorded without knowledge of the imaging findings.
e-ROP study examinations are continued as clinically indicated until the ophthalmologists note one of the following: (1) mature retinal vessels; (2) immature vessels in zone III on two occasions at least 7 days apart; (3) ROP regressed or regressing on two occasions at least 7 days apart; (4) treatment for severe ROP, or; (5) 40 weeks PMA reached with no ROP or only stage 1 or 2 ROP noted.
ROP Imaging
All e-ROP imaging sessions are conducted by a CRI, a non-physician who underwent extensive training in the use of the RetCam, a wide-field imaging camera system using a 130 lens. A range of individuals became CRIs including NICU nurses, neonatal nurse practitioners, ophthalmic photographers, an optical coherence tomography technician, and ophthalmic technologists. Certification consisted of onsite training by an experienced retinal imager from Clarity submitting a series of three right eye and three left eye image sets of six images each to the e-ROP reading center for review, and feedback, and resubmission until satisfactory, a site visit from the office of study chair to evaluate imaging, and completion of a series of knowledge assessments. Enrolled infants undergo a series of image sessions in both eyes prior to or after the diagnostic examination. The two procedures are almost always consecutive as stipulated in the manual of procedures, and the interval cannot exceed 24 hours. Due to poor image quality often encountered in infants 532 weeks PMA, and the very infrequent occurrence of severe ROP in such young infants, imaging is conducted at 32 weeks PMA or later, along with diagnostic examinations routinely indicated for the infant. At each image session, a standard image set is collected for each eye and include an image of the anterior segment and five retinal fields where the image had the disc central, right, left, up, and down. A RetCam video at 15 frames per second and up to 2 minutes in length is captured, and the image set for each eye is selected from the video for uploading after stepping away from the infant's bed.
Data Coordinating
Noteworthy ocular or systemic events are recorded into the retinal imager form. The reason for any interruption or termination of the imaging session is recorded. The imagers are unaware of the ocular findings of the diagnostic examination.
Data and Image Transmission from the Clinical Centers
As shown in Figure 3 , all study data including subject demographic information, safety and diagnostic examination results, and image sets from each infant imaged at the clinical centers are electronically transmitted directly from the clinical center to a secure server at the IRDC in Oklahoma City. For each image set, the CRI selects an optimal image set from RetCam, sorts and assigns them to the correct eye and specific field imaged. Images are transferred from the camera hard disk to a designated memory stick and in turn transferred via USB port to the dedicated IRDC server using 256-bit encryption over a secure Internet connection. All data are maintained on the IRDC server with remote back up servers and full disaster recovery plan. Only anonymized study data with no protected health information is included in the data uploaded to the IRDC server.
The DCC has secure access to the IRDC server and downloads data regularly to monitor enrollment, data quality and safety, and select images for grading. Image sets are selected for grading by the DCC and assigned and queued for grading by e-ROP readers. Image sets are accessed from the IRDC server for grading by readers at the image reading center at the University of Pennsylvania and for grading by expert readers (ophthalmologists) in Calgary, Alberta, Canada, and Royal Oak, Michigan, and Atlanta, Georgia, USA.
Selecting Images for Grading
Even though images of both eyes from all imaging sessions are submitted to the IRDC server, only images from some infants are selected for grading, as a high percentage of infants (485%) are not expected to develop RW-ROP. We randomly select approximately 600 infants who did not develop RW-ROP at any examination to minimize the time in grading many normal images, but retain the ability to estimate precisely specificity. All image sets from the random sample of infants without RW-ROP and all image sets from infants who had developed RW-ROP based on diagnostic examination (anticipated n = 250) are selected for grading by the trained readers. The purpose of including all RW-ROP-positive infants is to enrich the population of cases for the calculation of sensitivity. A subset of infants (n = 255, 30%) whose images are graded by trained readers are also graded by expert readers, for the purpose of comparing performance of trained readers and expert readers. This sample is enriched with half of the image sets from RW-ROP cases.
Certification of Trained Readers
Trained readers (all non-medical personnel) attended technical group meetings, as well as a training meeting with the expert readers, and completed general and role-specific knowledge assessments. Trained readers completed suggested readings recommended by the expert readers. In addition, they had several didactic sessions on identification of ROP using RetCam images, reviewed example images sets, and graded on non-e-ROP image sets. They then practiced grading sets of images of various levels of ROP severity along with an expert reader and followed with practice grading independently for 2 weeks, meeting with expert readers to review their grading. Finally, the trained readers graded a set of certification images that contain varying levels of ROP, varying quality and completeness of the image set to assess agreement with other readers and the expert readers.
Image Grading by Readers
Inoveon Corporation (Oklahoma City, OH, USA) developed the image grading application according to the specifications defined by the research team. The system analyst at the DCC assigns image sets and establishes reading queues for the trained readers, reading supervisor, clinical supervisor, and expert readers. Readers are masked from all diagnostic exam and demographic data. When any reader logs into the web-based e-ROP viewer application, they are notified of image sets available for reading and are permitted to download them for grading and completion of the grading form. All image sets assigned to the trained reader queue are read independently by two trained readers. Once an image set is downloaded for grading by a trained reader, it is unavailable to the second trained reader until the first grading is completed. Grading is done in a systematic manner by all readers using the same web-based e-ROP viewer (see Figure 4) following the evaluation system laid out in the grading protocol.
Each reader grades the quality of each image, as good, adequate, or poor, based on focus, clarity, and field definition. The reader then determines the following: (1) whether the vessels of the posterior pole are sufficiently abnormal to be designated as preplus or plus disease; (2) the extent of retinal vascularization by zone, and; (3) whether a demarcation line, ridge, extraretinal neovascularization, flat extraretinal neovascularization, or retinal detachment is present, and location (zone I, II, III) if present. In addition, the reader notes other findings and comments on the image set. Once finalized by the reader, gradings cannot be changed. When an image set has been graded by two trained readers, gradings are compared by the image grading system and if agreement is within pre-determined adjudication rules, a final reading record is created for the trained readers. If there are discrepancies beyond the threshold of the adjudication rules, a final record is not created and the system places the image set with discrepant answers in a queue for the reading supervisor who grades only those fields with discrepancies resulting in a final adjudicated record. Rarely, the reading supervisor requests further review by the clinical adjudicator who then grades only the fields with discrepancies using the same web-based form. The system then generates a final adjudicated reading record using the final gradings by the clinical adjudicator. 
Expert Readers
The three expert readers are retinal specialists with substantial experience in diagnosis and treatment of ROP, along with participation in ROP clinical trials. For e-ROP certification, expert readers were required to complete a role-specific knowledge assessment along with successful grading of pre-certification and certification image sets. The clinical supervisor and the reading supervisor also completed this certification process.
Using the same web-based e-ROP viewer system, each expert reader completes a subset of the image sets assigned to trained readers. Each image set assigned is graded by a single expert reader except for quality control image sets.
Primary Outcome Measure
The primary purpose of the e-ROP study is to determine the validity (as determined by the sensitivity and specificity) of detecting RW-ROP from gradings by trained readers of image sets obtained by CRIs, compared to results of a diagnostic examination of that eye by an ophthalmologist experienced in ROP evaluation.
RW-ROP has three major components that are not mutually exclusive: (a) any ROP present in zone I; (b) any stage 3 or worse ROP, and/or; (c) plus disease defined as sufficient abnormalities of the posterior pole vessels (dilation and tortuosity) as defined by standard photographs, and noted in at least two quadrants. The results of the Early Treatment for Retinopathy of Prematurity trial 31 provide further support for the criteria used for our definition of RW-ROP, which encompasses type 1 or type 2 ROP.
Secondary Outcome Measures
Four other important measures (reliability, feasibility, safety and cost-effectiveness) to evaluate an ROP telemedicine system are being undertaken. Intrareader and inter-reader agreement is used to assess the reliability of image grading for RW-ROP. Feasibility is assessed by determining whether image sets could be obtained for each infant and whether the images obtained are of sufficient quality for grading. Safety of the system is evaluated by comparing ocular and systemic complications related to imaging versus the diagnostic examination. Finally, the costs and benefits of adopting a telemedicine imaging system for ROP is compared to the current cost of diagnostic examinations.
Sample Size
The sample size was determined by the need to estimate sensitivity of the telemedicine system within ± 0.05 (i.e. the half width of the 95% confidence interval, CI, is 0.050) in a population in which the overall prevalence of RW-ROP would be approximately 14%. This was assumed to be a sufficient sample to provide a precise estimate for specificity because the majority of infants would not develop RW-ROP.
For primary outcome sample size calculations, the following assumptions were made: (1) Sensitivity and specificity for detecting eyespecific RW-ROP is between 0.80 and 0.95. (2) Desired precision of the sensitivity and specificity estimate is within ± 0.050, the RW-ROP rate is 14%, based on data obtained from the participating clinical centers. (3) Among infants with RW-ROP, RW-ROP is seen in both eyes in 80% of infants at first diagnosis, while in only one eye in 20% of infants.
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(4) All infants will undergo clinically indicated diagnostic examinations and thus eye examination results will be available. For image grading to determine the presence of RW-ROP, a random sample of infants without RW-ROP (n = 600) and all infants with RW-ROP will be selected. The unit of analysis is per-eye, and appropriate statistical analytic techniques will be used to account for inter-eye correlation in RW-ROP status. (5) In 10% of enrolled infants, it will not be possible to include their data in sensitivity/specificity calculations due to absence of data from imaging evaluations and/or diagnostic examination, or due to the loss of follow-up before status of RW-ROP could be determined. Sample size calculations indicated the need for 250 infants (450 eyes) with RW-ROP. Assuming the RW-ROP rate of 14%, we seek a total enrollment of 2000 infants in order to identify 250 infants with RW-ROP. Table 2 shows the precision of the estimate of sensitivity from these 250 infants with RW-ROP and specificity from 600 infants without RW-ROP for sensitivity/specificity values between 0.80 and 0.95. Such a sample size provides a precise estimate of both sensitivity and specificity (half width of 95% CI range 0.026-0.048 for sensitivity, and 0.017-0.031 for specificity).
STATISTICAL ANALYSIS
The primary analysis of validity requires the calculation of sensitivity and specificity for the trained reader's evaluation of each digital image set from an eye compared to the results of the diagnostic examination performed by the clinical center ophthalmologist at the same session. The outcome of the imaging evaluation for an eye is: (a) RW-ROP present (test positive); (b) RW-ROP absent (test negative), or; (c) Unable to determine if RW-ROP present or absent (indeterminate).
Eyes with ''indeterminate'' status are scored as test positive, since the primary aim of this study is to determine whether an expert opinion should be sought and, in the case of an indeterminate imaging evaluation, an expert opinion is warranted.
The result of the diagnostic examination constitutes the ''gold standard'' for sensitivity and specificity calculation. Diagnostic examination outcome is categorized as ''RW-ROP present'' (disease positive) or ''RW-ROP absent'' (disease negative) or ''indeterminate'' (i.e. the clinical center ophthalmologist is unable to determine the presence or absence of RW-ROP). Eyes with ''indeterminate'' status based on diagnostic examination are excluded from the analysis of sensitivity and specificity.
All enrolled infants undergo serial sessions of digital imaging and concurrent diagnostic examinations of both eyes. There are several ways to define the sensitivity and specificity for such data from multiple image evaluations and diagnostic examinations, depending on how many pairs and which pair(s) of digital image/diagnostic examinations are used. Due to its simplicity and ease of interpretation, we include only one pair of digital image/diagnostic examinations from each eye in the primary analysis. For sensitivity calculation, the pair when diagnostic examinations first identify RW-ROP is used, while a random pair is chosen for each eye that does not develop RW-ROP for the specificity calculation. Sensitivity is calculated as the proportion of positive image evaluations at the examination at which the RW-ROP is first identified by diagnostic examination. Specificity is calculated as the proportion of RW-ROP-negative diagnostic examinations that are imaging evaluation negative, using the randomly selected pair of digital image/diagnostic examinations for eyes that are RW-ROP negative in all sessions of diagnostic examinations.
The sensitivity calculated using this approach could be interpreted as probability of detecting RW-ROP by image evaluation system when RW-ROP is first noted by diagnostic examinationsthe most important parameter in evaluating imaging systems. By using a randomly selected pair for specificity analysis, the impact of PMA at the time of the diagnostic examination on the specificity estimate is minimized.
The 95% CIs are calculated for sensitivity and specificity. Because images from both eyes of an infant are evaluated, inter-eye correlations exist in these data. In such cases, point estimates of sensitivity and specificity remain valid without adjusting for intereye correlation, but for CI calculation the correlations from paired eyes need to be adjusted by generalized estimating equations 34 where the sandwich robust estimate of variance is applied. 35 
RESULTS
The study has enrolled 1284 infants as of October 31, 2013 . Demographic characteristics of the infants are provided in Table 3 . The mean birth weight was 865 g and mean GA was 27 weeks. The majority of infants were white and nonHispanic or Latino.
The process of certification of the trained readers included, after extensive training, the grading of 15 image sets by all readers (trained readers, expert readers and two adjudicator ophthalmologists) and comparing agreement between each trained reader with the majority of ophthalmologist readers. There was excellent agreement for each trained reader, with percent of agreement ranging from 93-100% (93% indicates that one of the 15 images did not agree with the ophthalmologist readers).
DISCUSSION
The e-ROP study addresses the question of whether a telemedicine system using remote evaluation of digital images by trained readers can reliably detect, in at-risk infants, eyes that have clinical features of potentially serious ROP and are in need of a diagnostic evaluation by an ophthalmologist experienced in ROP. The large-scale, multicenter e-ROP study will determine the validity of comparing grading by trained non-physician readers of images obtained by non-physician imagers with the results of diagnostic examinations conducted at the same session by an e-ROP-certified ophthalmologist. Importantly, assessments of feasibility, safety, and relative cost-effectiveness will also be made. To achieve the operational goals of the e-ROP study, we developed and used creative training techniques for retinal imagers and readers of digital retinal images. Further, all study data from the clinical centers are uploaded using web-based forms to a central server for remote grading by readers and analysis by the DCC. The study is powered to provide precise estimates of sensitivity and specificity, from which caregivers for at-risk infants can make informed decisions about whether such an approach is effective, safe, and feasible. In addition, the design and findings of the e-ROP study can be extended to support other ROP trials or evaluate telemedicine use for other diseases. 
